Local News

Dr. Keiichi Nakayama and a team of researchers at Kyushu University’s Medical Institute of Bioregulation have found that a certain protein will change the state of cancer stem cells, which are impervious to chemotherapy and radiation, into a state that allows them to be attacked. Even if the other cancerous cells are removed, the remaining cancer stem cells have the potential to create a recurrence of the disease. If the protein can be converted into a usable medicine, it might bring a cure within reach.